GetTopicDetailResponse(id=aa791400831, topicName=pegIFNα, introduction=pegIFNα, content=null, image=null, comments=0, allHits=1081, url=https://h5.medsci.cn/topic?id=14008, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=6147, tagList=[TagDto(tagId=6147, tagName=pegIFNα)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2248282, encodeId=6d3f2248282ff, content=<a href='/topic/show?id=aa791400831' target=_blank style='color:#2F92EE;'>#pegIFNα#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊導(dǎo)讀】新發(fā)現(xiàn)：血脂異?？赡苡绊慞egIFNα治療慢乙肝患者的療效, objectType=article, longId=858720, objectId=a7cb858e2081, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=a7cb858e2081, replyNumber=0, likeNumber=40, createdTime=2025-01-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=a7cb858e2081, moduleTitle=【期刊導(dǎo)讀】新發(fā)現(xiàn)：血脂異?？赡苡绊慞egIFNα治療慢乙肝患者的療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a7cb858e2081)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2209535, encodeId=75742209535ed, content=<a href='/topic/show?id=aa791400831' target=_blank style='color:#2F92EE;'>#pegIFNα#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=40a21153043b' target=_blank style='color:#2F92EE;'>#EASL2024#</a> <a href='/topic/show?id=65d511543e88' target=_blank style='color:#2F92EE;'>#抗-HBc水平#</a>, objectTitle=【EASL2024速遞】新證據(jù)：基線較高的抗-HBc水平與更好的PegIFNα治療療效相關(guān), objectType=article, longId=828021, objectId=612882802122, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240612/1718167913254_1608702.jpg, objectUrl=/article/show_article.do?id=612882802122, replyNumber=0, likeNumber=112, createdTime=2024-06-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=612882802122, moduleTitle=【EASL2024速遞】新證據(jù)：基線較高的抗-HBc水平與更好的PegIFNα治療療效相關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=612882802122)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
